AAAAAA

   
Results: 1-9 |
Results: 9
Physician recognition of active injection drug use in HIV-infected patients is lower than validity of patient's self-reported drug use
Authors: Messiah, A Loundou, AD Maslin, V Lacarelle, B Moatti, JP
Citation: A. Messiah et al., Physician recognition of active injection drug use in HIV-infected patients is lower than validity of patient's self-reported drug use, J PAIN SYMP, 21(2), 2001, pp. 103-112
Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers
Authors: Pageaux, GP Micallef, J Nataf, MB Levron, JC Lacarelle, B Le Moing, JP Bouhours, P Blin, O
Citation: Gp. Pageaux et al., Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers, BR J CL PH, 51(2), 2001, pp. 164-168
'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports andserum protease inhibitor concentrations in the French Manif 2000 cohort study
Authors: Duran, S Solas, C Spire, B Carrieri, MP Fuzibet, JG Costagliola, D Lacarelle, B Moatti, JP
Citation: S. Duran et al., 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports andserum protease inhibitor concentrations in the French Manif 2000 cohort study, AIDS, 15(8), 2001, pp. 1075-1077
Plasma, urine and skin pharmacokinetics of cefepime in burns patients
Authors: Sampol, E Jacquet, A Viggiano, M Bernini, V Manelli, JC Lacarelle, B Durand, A
Citation: E. Sampol et al., Plasma, urine and skin pharmacokinetics of cefepime in burns patients, J ANTIMICRO, 46(2), 2000, pp. 315-317
Relationship between efficacy, tolerance, and plasma drug concentration ofritonavir in children with advanced HIV infection
Authors: Dumon, C Solas, C Thuret, I Chambost, H Lacarelle, B Michel, G Durand, A
Citation: C. Dumon et al., Relationship between efficacy, tolerance, and plasma drug concentration ofritonavir in children with advanced HIV infection, THER DRUG M, 22(4), 2000, pp. 402-408
Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A
Authors: Gantenbein, M Attolini, L Bruguerolle, B Villard, PH Puyoou, F Durand, A Lacarelle, B Hardwigsen, J Le-Treut, YP
Citation: M. Gantenbein et al., Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A, DRUG META D, 28(4), 2000, pp. 383-385
Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit
Authors: Albanese, J Leone, M Bruguerolle, B Ayem, ML Lacarelle, B Martin, C
Citation: J. Albanese et al., Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit, ANTIM AG CH, 44(5), 2000, pp. 1356-1358
Panax vietnamensis protects mice against carbon tetrachloride-induced hepatotoxicity without any modification of CYP2E1 gene expression
Authors: Nguyen, TD Villard, PH Barlatier, A Elsisi, AE Jouve, E Duc, NM Sauze, C Durand, A Lacarelle, B
Citation: Td. Nguyen et al., Panax vietnamensis protects mice against carbon tetrachloride-induced hepatotoxicity without any modification of CYP2E1 gene expression, PLANTA MED, 66(8), 2000, pp. 714-719
CYP2E1 and CYP3A1/2 gene expression is not associated with the ursodeoxycholate effect on ethanol-induced lipoperoxidation
Authors: Nguyen, TD Oliva, L Villard, PH Puyoou, F Sauze, C Montet, AM Lacarelle, B Durand, A Montet, JC
Citation: Td. Nguyen et al., CYP2E1 and CYP3A1/2 gene expression is not associated with the ursodeoxycholate effect on ethanol-induced lipoperoxidation, LIFE SCI, 65(11), 1999, pp. 1103-1113
Risultati: 1-9 |